Intranasal fluticasone propionate in the pharmacotherapy of allergic rhinitis
- Authors: Astafieva N.G.1, Gamova I.V.1, Kobzev D.Y.2, Perfilova I.A.1, Udovichenko E.N.1, Aleschina L.V.1
-
Affiliations:
- Razumovsky Saratov State Medical University
- Leeds Trinity University, School of Health and Social Sciences
- Issue: Vol 23, No 9 (2021)
- Pages: 421-429
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95492
- DOI: https://doi.org/10.26442/20751753.2021.9.201059
- ID: 95492
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Natalia G. Astafieva
Razumovsky Saratov State Medical University
Email: astang@mail.ru
д-р мед. наук, проф., зав. каф. Saratov, Russia
Inna V. Gamova
Razumovsky Saratov State Medical University
Email: innapris@yandex.ru
канд. мед. наук, доц. каф. Saratov, Russia
Denis Yu. Kobzev
Leeds Trinity University, School of Health and Social Sciences
Email: d.kobzev@leedstrinity.ac.uk
проф. UK
Irina A. Perfilova
Razumovsky Saratov State Medical Universityканд. мед. наук, доц. каф. Saratov, Russia
Ekaterina N. Udovichenko
Razumovsky Saratov State Medical University
Email: udokate@mail.ru
канд. мед. наук, доц. каф. Saratov, Russia
Lybov V. Aleschina
Razumovsky Saratov State Medical University
Email: lubov-sk@mail.ru
канд. мед. наук, ассистент каф. Saratov, Russia
References
- Wise SK, Lin SY, Toskala E, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108-352. D0I:10.1002/alr.22073
- Bousquet J, Schunemann HJ, Togias A, et al; Allergic Rhinitis and Its Impact on Asthma Working Group. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. D0I:10.1016/j.jaci.2019.06.049
- Bousquet J, Schunemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367-74. doi: 10.1016/j.jaci.2016.03.025
- Bousquet J, Schunemann HJ, Hellings PW, et al; MASK study group. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367-74.e2. doi: 10.1016/j.jaci.2016.03.025
- Fokkens W, Lund V, Hopkins HP, et al. EP0S2020: European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. S29):1464.
- Global atlas of allergic rhinitis and chronic rhinosinusitis. Ed. CA Akdis, PW Hellings, I Agache, et al. Zurich, Switzerland: European Academy of Allergy and Clinical Immunology, 2015.
- Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474-94. doi: 10.1111/all.12573
- Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines -2016 Revision. JAllergy Clin Immunol. 2017;140(4):950-8. D0I:10.1016/j.jaci.2017.03.050
- Аллергический ринит. Федеральные клинические рекомендации. Российский аллергологический журнал. 2018;4:43-53
- Аллергический ринит. Клинические рекомендации. Российская ассоциация аллергологов и клинических иммунологов; Национальная медицинская ассоциация оториноларингологов; Союз педиатров России. 2021. Режим доступа: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy. Ссылка активна на 11.08.2021
- Астафьева Н.Г., Кобзев Д.Ю., Гамова И.В., и др. Многоликий ринит: современный взгляд на диагностику и алгоритм лечения. Лечащий врач. 2018;4:7-18
- Bousquet J, Schunemann HJ, Fonseca J, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015;70:1372-92.
- Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl. S29):1-464. D0I:10.4193/Rhin20.600
- Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health 0rganization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl. 86):8-160. D0I:10.1111/j.1398-9995.2007.01620.x
- Settipane RA, Kaliner MA. Nonallergic rhinitis. Am J Rhinol Allergy. 2013;27(Suppl. 1):S48-51.
- Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-65. D0I:10.1111/all.13200
- Poddighe D, Gelardi M, Licari A, et al. Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management. World J Methodol. 2016;6(4):200-13. D0I:10.5662/wjm.v6.i4.200
- Астафьева Н.Г., Удовиченко Е.Н., Гамова И.В., и др. Аллергические и неаллергические риниты: сравнительная характеристика (часть 1). Лечащий врач. 2013;4:10-2
- Шамкина П.А., Кривопалов А.А., Рязанцев С.В., и др. Эпидемиология хронических риноси-нуситов. Современные проблемы науки и образования. 2019;3:152. Режим доступа: https:// science-education.ru/ru/article/view?id=28891. Ссылка активна на 09.08.2021
- Острый риносинусит: клинические рекомендации. Под ред. А.С. Лопатина. М., 2017
- Тюфилин Д.С., Деев И.А., Кобякова О.С., и др. Контроль аллергического ринита: современные инструменты оценки. Бюллетень сибирской медицины. 2019;18(2):262-71
- Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474-94. D0I:10.1111/all.12573
- Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36. D0I:10.1186/s13601-015-0080-9
- Клинические рекомендации. Аллергический ринит. Российская ассоциация аллергологов и клинических иммунологов; Национальная медицинская ассоциация оториноларингологов; Союз педиатров России. 2021. Режим доступа: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy. Ссылка активна на 11.08.2021
- Brozek JL, Bousquet J, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines -2016 revision. J Allergy Clin Immunol. 2017;140(4):950-8. D0I:10.1016/j.jaci.2017.03.050
- Pfaar 0, Klimek L, Gerth van Wijk R. Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis. Curr Opin Allergy Clin Immunol. 2015;15(3):197-203. D0I:10.1097/ACI.0000000000000164
- Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36. D0I:10.1186/s13601-015-0080-9
- Хаитов М.Р., Намазова-Баранова Л.С., Чучалин А.Г., и др. ARIA 2016: Современные направления оказания медицинской помощи больным аллергическим ринитом в свете требований прецизионной медицины. Российский аллергологическийжурнал. 2017;14(3):46-54
- Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and longterm use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:1. D0I:10.1186/s13601-019-0303-6. Erratum in: Clin Transl Allergy. 2020;10:38. PMID: 31908763; PMCID: PMC6941282.
- Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Br Med J. 1973;4(5890):464-6. D0I:10.1136/bmj.4.5890.464
- Samolinski B, Nowicka A, Wojas 0, et al. Intranasal glucocorticosteroids - not only in allergic rhinitis In the 40th anniversary of intranasal glucocorticosteroids' introduction. Otolaryngol Pol. 2014;68(2):51-64. D0I:10.1016/j.otpol.2013.12.003
- Bachert C, Bousquet J, Hellings P Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018;8:25. doi: 10.1186/s13601-018-0210-2
- Van As A, Bronsky E, Grossman J, et al. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy. 1991;67(2 Pt. 1):156-62.
- Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol. 1998;101(4 Pt. 2):S434-9. doi: 10.1016/s0091-6749(98)70155-1
- Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-300. doi: 10.1111/j.1398-9995.2008.01750.x
- Grim C, Pierre LN, Daley-Yates PT. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin Ther. 2001;23(9):1339-54. doi: 10.1016/s0149-2918(01)80113-2
- Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueos nasal spray and disodium chromoglicate aqueous nasal spray. Allergy. 1993;48(5):327-33. doi: 10.1111/j.1398-9995.1993.tb02401.x
- Vervloet D, Defougeres JK, Charpin D. Fluticasone propionate aqueous nasal spray versus cetirizine in seasonal rhinitis. J Allergy Clin Immunol. 1992;89:304.
- Dolovich J, Wong AG, Chodirker WB, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy. 1994;73(2):147-53. PMID: 8067598.
- Gehanno P, Desfougeres JL. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy. 1997;52(4):445-50. doi: 10.1111/j.1398-9995.1997.tb01027.x
- Storms WW. Treatment of seasonal allergic rhinitis with fluticasone propionate aqueous nasal spray: review of comparator studies. Allergy. 1995;50(23 Suppl.):25-9. doi: 10.1111/j.1398-9995.1995.tb02738.x
- Small M, Piercy J, Demoly P, Marsden H. Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey. Clin Transl Allergy. 2013;3(1):33. doi: 10.1186/2045-7022-3-33
- DeWester J, Philpot EE, Westlund RE, et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;24:331-7.
- Berstein DI, Levy AL, Hamperl FC, et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy. 2004;34:952-7.
- Лопатин А.С. Кортикостероидная терапия в лечении заболеваний носа и околоносовых пазух: исторические аспекты. Consilium Medicum. 2004;6(4):280-3
- Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin. 2009;25(8):2021-41. doi: 10.1185/03007990903094106
- Ciprandi G, Canonica WG, Grosclaude M, et al. Effects of budesonide and fluticasone propionate in a placebocontrolled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy. 2002;57:586-91.
- Bielory L, Gross GN, Letierce A, et al. Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: A meta-analysis. Ann Allergy Asthma Immunol. 2020;124(6):616-21.e3. doi: 10.1016/j.anai.2020.01.012.
- Allen DB, Meltzer EO, Lemanske RF Jr., et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc. 2002;23(6):407-13.
- Settipane RA, Kaliner MA. Chapter 14: Nonallergic rhinitis. Am JRhinol Allergy. 2013; 27(Suppl. 1):S48-51.
- Kaliner MA. Nonallergic rhinopathy (formerly known as vasomotor rhinitis). Immunol Allergy Clin North Am. 2011;31(3):441-55.
- Singh U, Bernstein JA, Haar L, et al. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014;28:215-24.
- Астафьева Н.Г., Гамова И.В., Кобзев Д.Ю., и др. Нестероидные противовоспалительные препараты как причина обострения астмы и других респираторных заболеваний: диагностика и лечение (ч. 2). Лечащий врач. 2016;5:82-8
- Astafieva N, Kobzev D, Gamova I, et al. Efficacy and safety of fluticasone propionate and its generic among patients with nonallergic rhinopathy. Allergy. 2012;67 (Suppl. 96).
- Резолюция совета экспертов «Актуализация клинических рекомендаций по острому ри-носинуситу и адаптация их к EPOS 2020». Режим доступа: https://egispro.ru/wp-content/uploads/2020/12/rezolyucziya-soveta-eksper-.pdf. Ссылка активна на 1 1.08.2021
- Crawford B, Stanford R, Wong AY, et al. Development of a questionnaire to assess experience and preference of intranasal corticosteroids in patients with allergic rhinitis. J Asthma Allergy. 2011;2:119-26.
- Bachert C, Pawankar R, Zhang L, et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7(1):25. doi: 10.1186/1939-4551-7-25
- Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479-90. doi: 10.1016/j.jaci.2013.02.036
- Grossman J, Banov C, Bronsky EA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics. 1993;92(4):594-9.
- Ridolo E, Caminati M, Martignago I, et al. Allergic rhinitis: pharmacotherapy in pregnancy and old age. Expert Rev Clin Pharmacol. 2016;9(8):1081-9. doi: 10.1080/17512433.2016.1189324
- Bozek A. Pharmacological Management of Allergic Rhinitis in the Elderly. Drugs Aging. 2017;34(1):21-8. doi: 10.1007/s40266-016-0425-7
- Remien K, Bowman A. Fluticasone. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2021. PMID: 31194318.
- McDonnell J, Weller K, Pien LC. Safety of Intranasal Steroids: an Updated Perspective. Curr Allergy Asthma Rep. 2020;20(11):69. doi: 10.1007/s11882-020-00960-2
- Berger W, Sher E, Gawchik S, Fineman S. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial. Allergy Asthma Proc. 2018;39(2):110-6. doi: 10.2500/aap.2018.39.4116
- Ilyina NI, Edin AS, Astafieva NG, et al. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia. Int Arch Allergy Immunol. 2019;178(3):255-63. doi: 10.1159/000494507
- Klimek L, Berger WE, Bousquet J, et al. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review. Int Arch Allergy Immunol. 2021:1-10. doi: 10.1159/000516417
- Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020;146(4):721-67. doi: 10.1016/j.jaci.2020.07.007
- Du K, Qing H, Zheng M, et al. Intranasal antihistamine is superior to oral H antihistamine as an addon therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(5):589-96.e3. doi: 10.1016/j.anai.2020.06.038
- Bousquet J, Schunemann H, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145:70-80.
- Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213-739. doi: 10.1002/alr.22741